The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections

Journal of Virology

Volumn 69, Issue 2, 1995, Pages 904-909

  Heise, Mark T ^a   Virgin IV, Herbert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; COMBINED IMMUNODEFICIENCY; CYTOMEGALOVIRUS INFECTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; INFLAMMATORY INFILTRATE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0028811975     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.69.2.904-909.1995     Document Type: Article

References (49)

1. Austyn, J. M., and S. Gordon. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:805-815.
2. Bancroft, G. J., M. J. Bosma, G. C. Bosma, and E. R. Unanue. 1986. Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism. J. Immunol. 137:4-9.
3. Bancroft, G. J., R. D. Schreiber, G. C. Bosma, M. J. Bosma, and E. R. Unanue. 1987. A T cell-independent mechanism of macrophage activation by interferon-gamma. J. Immunol. 139:1104-1107.
4. Bancroft, G. J., K. C. Sheehan, R. D. Schreiber, and E. R. Unanue. 1989. Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J. Immunol. 143:127-130.
5. Bancroft, G. J., G. R. Shellam, and J. E. Chalmer. 1981. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 126: 988-994.
6. Beller, D. I., and K. Ho. 1982. Regulation of macrophage populations. V. Evaluation of the control of macrophage Ia expression in vitro. J. Immunol. 129:971-976.
7. Booss, J., P. R. Dann, B. P. Griffith, and J. H. Kim. 1989. Host defense response to cytomegalovirus in the central nervous system: predominance of the monocyte. Am. J. Pathol. 134:71-78.
8. Bukowski, J. F., B. A. Woda, and R. M. Welsh. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52: 119-128.
9. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon-gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-879.
10. Chong, K. T., I. Gresser, and C. A. Mims. 1983. Interferon as a defense mechanism in mouse cytomegalovirus infection. J. Gen. Virol. 64:461-464.
11. Dobbins, J. G., J. A. Stewart, and G. J. Demmler. 1992. Surveillance of congenital cytomegalovirus disease, 1990-1991. Morbid. Mortal. Weekly Rep. 41:35-44.
12. Einhorn, L., and A. Ost. 1984. Cytomegalovirus infection of human blood cells. J. Infect. Dis. 149:207-213.
13. Fennie, E. H., Y. S. Lie, M. A. Low, P. Gribling, and K. P. Anderson. 1988. Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-gamma treatment. Antiviral Res. 10:27-39.
14. Haagmans, B. L., F. S. Stals, P. H. Van Der Meide, C. A. Bruggeman, M. C. Horzinek, and V. E. C. J. Schijns. 1994. Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. J. Virol. 68: 2297-2304.
15. Haller, B., and H. W. Virgin IV. Unpublished data.
16. Ibanez, C. E., R. Schrier, P. Ghazal, C. Wiley, and J. A. Nelson. 1991. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65:6581-6588.
17. Jonjic, S., W. Mutter, F. Weiland, M. J. Reddehase, and U. H. Koszinowski. 1989. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J. Exp. Med. 169:1199-1212.
18. Jonjic, S., I. Pavic, P. Lucin, D. Rukavina, and U. H. Koszinowski. 1990. Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J. Virol. 64:5457-5464.
19. Lathey, J. L., and S. A. Spector. 1991. Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J. Virol. 65:6371-6375.
20. Lewandowski, G. A., D. Lo, and F. E. Bloom. 1993. Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response. Proc. Natl. Acad. Sci. USA 90:2005-2009.
21. Lucin, P., S. Jonjic, M. Messerle, B. Polic, H. Hengel, and U. H. Koszinowski. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumor necrosis factor. J. Gen. Virol. 75:101-110.
22. Lucin, P., I. Pavic, B. Polic, S. Jonjic, and U. H. Koszinowski. 1992. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 66:1977-1984.
23. Maciejewski, J. P., E. E. Bruening, R. E. Donahue, E. S. Mocarski, N. S. Young, and S. C. St Jeor. 1992. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170-178.
24. Maciejewski, J. P., E. E. Bruening, R. E. Donahue, S. E. Sellers, C. Carter, N. S. Young, and S. St Jeor. 1993. Infection of mononucleated phagocytes with human cytomegalovirus. Virology 195:327-336.
25. Mercadal, C. M., D. M. Bouley, D. DeStephano, and B. T. Rouse. 1993. Herpetic stromal keratitis in the reconstituted scid mouse model. J. Virol. 67:3404-3408.
26. Mims, C. A., and J. Gould. 1978. The role of macrophages in mice infected with murine cytomegalovirus. J. Gen. Virol. 41:143-153.
27. Minton, E. J., C. Tysoe, J. H. Sinclair, and J. P. G. Sissons. 1994. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:4017-4021.
28. Pavic, I., B. Polic, I. Crnkovic, P. Lucin, S. Jonjic, and U. H. Koszinowski. 1993. Participation of endogenous tumour necrosis factor-alpha in host resistance to cytomegalovirus infection. J. Gen. Virol. 74:2215-2223.
29. Pollock, J., and H. W. Virgin IV. Latency without persistence of murine cytomegalovirus in spleen and kidney. Submitted for publication.
30. Price, P., J. G. Winter, S. Nikoletti, J. B. Hudson, and G. R. Shellam. 1987. Functional changes in murine macrophages infected with cytomegalovirus relate to H-2-determined sensitivity to infection. J. Virol. 61:3602-3606.
31. Price, P., J. G. Winter, and G. R. Shellam. 1987. Genetically determined resistance to murine cytomegalovirus: a role for lymphocytostatic macrophages. J. Gen. Virol. 68:2997-3008.
32. Rice, G. P. A., R. D. Schrier, and M. B. Oldstone. 1984. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sci. USA 81:6134-6138.
33. Rogers, H. K., K. C. F. Sheehan, L. M. Brunt, S. K. Dower, E. R. Unanue, and R. D. Schreiber. 1992. Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice. Proc. Natl. Acad. Sci. USA 89:1011-1015.
34. Rubin, R. H. 1990. Impact of cytomegalovirus infection on organ transplant recipients. Rev. Infect. Dis. 12(Suppl. 7):S754-S766.
35. Schooley, R. T. 1990. Cytomegalovirus in the setting of infection with human immunodeficiency virus. Rev. Infect. Dis. 12(Suppl. 7):S811-S819.
36. Schreiber, R. Personal communication.
37. Schreiber, R. D., L. J. Hicks, A. Celada, N. A. Buchmeier, and P. W. Gray. 1985. Monoclonal antibodies to murine gamma interferon which differentially modulate macrophage activation and antiviral activity. J. Immunol. 134:1609-1618.
38. Shanley, J. D. 1990. In vivo administration of monoclonal antibody to the NK 1.1 antigen of natural killer cells: effect on acute murine cytomegalovirus infection. J. Med. Virol. 30:58-60.
39. Shanley, J. D., and E. L. Pesanti. 1983. Murine peritoneal macrophages support murine cytomegalovirus replication. Infect. Immun. 41:1352-1359.
40. Sheehan, K., and R. Schreiber. Personal communication.
41. Sheehan, K. C., N. H. Ruddle, and R. D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol. 142:3884-3893.
42. Smith, M. G. 1954. Propagation of salivary gland virus of the mouse in tissue culture. Proc. Soc. Exp. Biol. Med. 86:435-440.
43. Stoddart, C. A., R. D. Cardin, J. M. Boname, W. C. Manning, G. B. Abenes, and E. S. Mocarski. 1994. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68:6243-6253.
44. Taylor-Wiedemann, J., J. P. G. Sissons, L. K. Borysiewicz, and J. H. Sinclair. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72:2059-2064.
45. Taylor-Wiedeman, J., P. Sissons, and J. Sinclair. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1597-1604.
46. Tegtmeyer, P. J., and J. E. Craighead. 1968. Infection of adult mouse macrophages in vitro with cytomegalovirus. Proc. Soc. Exp. Biol. Med. 129:690-694.
47. Virgin, H. W., M. A. Mann, B. N. Fields, and K. L. Tyler. 1991. Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J. Virol. 65:6772-6781.
48. Weigent, D. A., J. G. Stanton, and H. M. Johnson. 1983. Interleukin-2 enhances natural killer cell activity through induction of gamma interferon. Infect. Immun. 41:992-997.
49. Welsh, R. M., J. O. Brubaker, M. Vargas Cortes, and C. L. O'Donnell. 1991. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency: the stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J. Exp. Med. 173:1053-1063.